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Introduction
Soybean contains considerable amounts of compounds col-
lectively called isoflavone, which mainly exist as glycoside.
Among soy isoflavones, the predominant compounds of agly-
con are daidzein, genistein and glycitein. Soy isoflavone has
various meritorious physiological activities to prevent post-
menopausal symptoms, prostate and breast cancers, cardio-
vascular disease, and osteoporosis
1). Genistein, daidzein and
its intestinal bacterial metabolite equol are considered to be
ligands of estrogen receptor2). Also, genistein but not daidzein
was found to be an activator of peroxisome proliferator-acti-
vated receptor (PPAR) α3,4). Therefore, it is possible that the
pleiotropic physiological effects of isoflavone are mediated
through the alterations in the expression of genes targeted by
these nuclear receptors. 
Sterol regulatory element-binding protein (SREBP)-1 is a
transcription factor that regulates the expression of genes
involved in lipogenesis5). Also, several genes involved in
fatty acid desaturation are controlled by this transcription fac-
tor5). There are two isoforms of SREBP-1, termed SREBP-1a
and -1c, that are derived from a single gene through the use of
an alternative transcriptional start site. It has been reported
that isoflavone aglycons decreased serum and liver triglyc-
eride levels in rats6) and diabetic mice7). In addition, dietary
isoflavone lowered the activity of hepatic Δ6-desaturase6)
which is known as one of the genes modulated by SREBP-18).
These studies raise the possibility that soy isoflavone not only
affects nuclear receptor-dependent metabolic pathways, but
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Abstract
The effect of soy isoflavone on mRNA expression of sterol regulatory element-binding protein (SREBP)-1 isoforms and the tar-
get genes of SREBP-1 involved in fatty acid metabolism was examined in rats. Animals were fed a 20% palm oil diet containing
0, 0.05, 0.1, 0.2, or 0.4% of soy isoflavone for 14 d. The diets containing 0.1, 0.2, and 0.4% of isoflavone significantly increased
the mRNA level of hepatic SREBP-1a to a similar level compared to a diet containing 0.05% of isoflavone or a diet free of
isoflavone. In contrast, diets containing 0.05-0.2% isoflavone, compared to a diet free of isoflavone, did not influence the mRNA
level of SREBP-1c. However, a diet containing 0.4% of isoflavone lowered this parameter to one half that observed with an
isoflavone-free diet. Dietary isoflavone dose-dependently increased the mRNA levels of genes targeted by SREBP-1 (fatty acid
synthase, stearoyl-CoA desaturase 1 and Δ6-desaturase), and they peaked at a dietary level of 0.1 or 0.2%. However, a diet con-
taining 0.4% of isoflavone decreased these parameters to the levels observed in rats fed an isoflavone-free diet. Thus, it is appar-
ent that varying amounts of dietary isoflavone modulate mRNA expressions of SREBP-1a and -1c differently. The contours of
the changes in the gene expressions of SREBP-1 isoforms may account for the biphasic modulation by different dietary levels of
isoflavone in the mRNA expression of the genes targeted by these transcriptional factors.
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also modulates the expression of the genes under the control
of SREBP-1 and hence affects lipogenesis. The observation
that genistein and daidzein did not affect SREBP-1 expres-
sion in cultured hepatic cells may be contrary to this
notion9,10). However, studies regarding the impact of
isoflavone on mRNA expression of SREBP-1 in experimental
animals have been lacking. To examine the hypothesis that
soy isoflavone modulates lipogenesis through SREBP-1-
dependent mechanism, we analyzed the effect of a prepara-
tion rich in isoflavone glycosides made of soybean on gene
expressions of SREBP-1a and -1c, and some of their target
genes in rat liver. We used high saturated-fat diets for this
purpose, since a previous study showed that a high saturated-
fat diet evoked more than 7-fold and approximately 2-fold
increase in mRNA expression of SREBP-1c and -1a, respec-
tively, in mice
11).
Materials and Methods
Animals and diets 
Male Sprague-Dawley rats obtained from Charles River
Japan (Kanagawa, Japan) at 4 weeks of age were housed indi-
vidually in a room with controlled temperature (20-22℃),
humidity (55-65%), and lighting (lights on from 07:00 to
19:00 h) and fed a commercial nonpurified diet (Type NMF;
Oriental Yeast, Tokyo, Japan). After 7 d of acclimatization in
our housing condition, rats were randomly divided into 5
groups and fed for 14 d the purified experimental diets con-
taining varying amounts (0, 0.11, 0.21, 0.43 and 0.85%) of a
preparation rich in soy isoflavone glycosides (Soyaflavone
HG) kindly donated from Fuji Oil Co. Ltd. Osaka, Japan. As
the soy isoflavone preparation contained 47.0% (w/w)
isoflavones, our experimental diets contained 0, 0.05, 0.1, 0.2
and 0.4% of soy isoflavone. The composition of the
isoflavones in the preparation were (in weight %): daidzin,
33.8; glycitin, 16.4; genistin, 6.89; malonyl daidzin, 25.5;
malonyl glycitin, 9.68; malonyl genistin, 6.09; acetyl daidzin,
0.54; acetyl glycitin, 0.80; acetyl genistin, 0.13; daidzein,
0.07; glycitein, 0.06, and genistein, 0.02. Thus, our experi-
mental diets contained isoflavone aglycons in the following
composition (in weight %): daidzein, 59.9; glycitein, 27.0,
and genistein, 13.1. The basal composition of the experimen-
tal diet was (in weight %): casein, 20; palm oil, 20; corn
starch, 15; cellulose, 2; mineral mixture
12), 3.5; vitamin mix-
ture12), 1.0; L-cystine, 0.3; choline bitartrate, 0.25 and sucrose
to 100. Soy isoflavone was added to experimental diets
instead of sucrose. Body weight at the start of experiment was
119-138 g. Animals had free access to the diets and water
during the experiment. At the end of the experiment, the ani-
mals were sacrificed by bleeding from the abdominal aorta
under diethyl ether anesthesia. Livers were then quickly
excised and weighed. This study followed the institute’s
guidelines in the care and use of laboratory animals.
RNA analysis
RNA in the liver was extracted13), and mRNA levels of
specific genes were analyzed by a quantitative real-time PCR
using a PRISM 7000 sequence detection system (Applied
Biosystems, Foster City, CA) as detailed previously14).
mRNA abundance was calculated as its ratio to the 18S rRNA
level in each cDNA sample and the abundance was expressed
as a percentage assigning the value in rats fed a isoflavone-
free diet as 100. The nucleotide sequences of primers and
probes to detect each mRNA were designed using the Primer
Express Software (Applied Biosystems) according to the
sequences available from the GenBank database. The
nucleotide sequences of primers and probes for SREBP-1a,
SREBP-1c, fatty acid synthase, and 18S rRNA were the same
as reported elsewhere15). Those for forward and reverse
primers and probes to detect mRNA of stearoly-CoA desat-
urase 1 were:
5’-TTGCCAGAGGGAATAGGGAAA-3’, 
5’-CTCTCCCATCCTTACTTACAAACCA-5’, and 
5’-ACCGTGCGTGCTAATTCTTCTCTCAAGGT-5’,  and of
Δ6-desaturase were 5’-ACCGCTGCTCATCCCTATGT-3’,
5’-CACCCAGTCTCTGCGTCTGA-3’, and
5’-TTCCAGTACCAGATCATCATGACCAT-3’, respectively.
Analysis of isoflavone in serum
One hundred μl of 0.58 M acetic acid and 50 μl of a β-
glucuronidase prepatation (Type HP2, Sigma, St. Louis, MO)
were added to 1 ml of serum, and incubated at 37℃ for 4 h.
After the enzymatic hydrolysis, each serum sample was
spiked with 6 μg of fluorescein dissolved in 50 μl of
methanol as an internal standard, and 4 ml of 70 mM sodium
dihydrogenphosphate was added. Isoflavones in the samples
were extracted using solid phase extraction cartridges (Sep-
Pak C18 cartridge, Waters, Milford, MA). The cartridges
were preconditioned with 6 ml each of methanol and 70 mM
sodium dihydrogenphosphate. The samples were loaded onto
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then consecutively washed with 10 ml of 70 mM sodium
dihydrogenphosphate and 2 ml of water. Isoflavones and an
internal standard were eluted with 6 ml of methanol, then
dried under nitrogen and re-constituted with 200 μl of
methanol for HPLC analysis. Isoflavones were analyzed by a
reversed-phase HPLC using a CAPCELL PAK AG120 C18
column (250 x 4.6 mm, Shiseido, Tokyo, Japan) with a
mobile phase of 0.5% phospholic acid in water/acetonitrile
(70:30, v/v), at a flow rate of 1.0 ml/min, monitoring at 259
nm for isoflavones and 224 nm for fluorescein.
Statistical analysis
The data were analyzed by one-way ANOVA, and a
Tukey-Kramer post hoc analysis was used to detect signifi-
cant differences between the means at a level of p<0.05.
Results
Animal growth and liver weights 
No significant differences were detected in food intake
among the groups of rats fed diets containing varying
amounts of isoflavone (18.1-20.2 g/d). The growth was sig-
nificantly lower in rats fed a diet containing 0.4% of
isoflavone (127 ± 5 g/14 d) than in the animals fed diets con-
taining 0.05 and 0.1% of isoflavone (145 ± 8 and 147 ± 7
g/14 d, respectively). However, significant differences were
not detected among rats fed diets containing 0% (137 ± 4
g/14 d), 0.2% (143 ± 6) and 0.4% of isoflavone. Liver
weight was significantly lower in rats fed a diet containing
0.4% of isoflavone (5.18 ± 0.14 g/100 g body weight) than
in the animals fed a diet containing 0.2% of isoflavone (5.77
± 0.18). No other significant differences in this parameter
were detected among the groups.
Serum isoflavone concentrations
Isoflavone was not detected in the serum of rats fed on an
isoflavone-free diet. As expected, serum concentrations of
daidzein, glycitein and genistein progressively increased as
dietary levels of isoflavone increased (Table 1). Daidzein,
glycitein and genistein comprised 62.5, 25.2 and 12.3% of
total isoflavone in the serum of rats fed a 0.05% isoflavone
diet. These values were comparable to the proportions con-
tained in experimental diets (58.5, 28.5 and 13.1%, respec-
tively). However, the proportions of daidzein in serum were
considerably higher in rats fed 0.1, 0.2 and 0.4% isoflavone
diets (75.3-77.6%) than in the animals fed a 0.05% isoflavone
diet. This was accompanied by the decreases in the propor-
tions of both glycistein (14.7-18.3%) and genistein (5.0-
7.7%).
mRNA levels of SREBP-1a and -1c and their tar-
get genes
We quantified the mRNA levels of SREBP-1a and -1c that
were involved in the regulation of gene expression of various
lipogenic enzymes16) and some enzymes involved in fatty
acid desaturation8). mRNA level of SREBP-1a was compara-
ble between rats fed diets containing 0 and 0.05% of
isoflavone (Fig. 1). However, diets containing 0.1, 0.2 and
0.4% of isoflavone, compared to an isoflavone-free diet,
caused significant 68, 98, and 64% increases, respectively, in
this parameter. Response to dietary isoflavone of mRNA
expression of SREBP-1c was considerably different. Diets
containing 0.05-0.2% of isoflavone, compared to an
isoflavone-free diet, did not affect mRNA expression of
SREBP-1c, but a diet containing 0.4% of isoflavone signifi-
Table 1. Serum concentration of isoflavones in rats fed diets containing varying amounts of soy
isoflavone
cantly reduced the mRNA level (Fig. 1). 
The mRNA levels of SREBP-1-dependent genes, involved
in fatty acid synthesis (fatty acid synthase17)), and fatty acid
desaturation (stearoyl-CoA desaturase 118) and Δ 6-
desaturase8)) were also analyzed (Fig. 2). The responses of
mRNA expression of these enzymes to dietary isoflavone
were biphasic. Increasing dietary levels of isoflavone up to
0.1% up-regulated the mRNA levels of these enzyme genes.
However, a diet containing 0.2% isoflavone failed to cause
additional increases in the mRNA levels, and isoflavone at a
0.4% dietary level decreased the mRNA levels comparable to
those observed in rats fed an isoflavone-free diet. 
Discussion
Previous studies have demonstrated that soy isoflavone
lowers serum triacylglycerol concentration in experimental
animals19-21). We hypothesized in the present study that alter-
ations in the gene expression of SREBP-1 and consequently
of its target genes may account for triacylglycerol-lowering
effect of genistein and daidzein in experimental animals. Our
study showed that dietary isoflavone modulates mRNA
expression of SREBP-1a and -1c isoforms differently in the
liver according to its dietary levels. These changes were
accompanied by the alterations in the mRNA expression of
some SREBP-1-dependent enzymes. 
The present study demonstrated that a relatively high dose
of dietary isoflavone down-regulates mRNA level of SREBP-
1c, whereas isoflavone at dietary levels greater than 0.1%
increases the mRNA level of SREBP-1a. Shimomura et al.
reported that mRNA level of SREBP-1c exceeded that of
SREBP-1a in tissues of mice, including liver (8.8-fold in
liver)
22). Thus, it is generally considered that SREBP-1c but
not SREBP-1a is primarily involved in the regulation of lipo-
genesis and fatty acid desaturation in the liver. On the other
hand, it is reported that transcriptional activity of SREBP-1c
is much weaker than that of SREBP-1a due to its shorter tran-
scriptional regulatory domain23). In fact, Amemiya-Kudo et
al. demonstrated that over-expression of SREBP-1a in mice
profoundly increased mRNA levels of several genes involved
in lipogenesis in liver, whereas SREBP-1c over-expression
caused only moderate increase in these values17). In the pres-
ent study, isoflavone at dietary levels of 0.1 and 0.2%
increased mRNA expression of SREBP-1-dependent genes
(Fig. 2). The contours of the changes paralleled that of
SREBP-1a but not of SREBP-1c (Fig. 1). This observation
suggests that the former but not the latter is mainly involved
in the regulation of SREBP-1-dependent genes under these
nutritional conditions. A diet containing 0.4% of isoflavone
decreased mRNA expression of SREBP-1-dependent genes
even though SREBP-1a mRNA level was still sustained at a
high level (Fig. 2). Thus, the down-regulation of the expres-
sion of SREBP-1c observed at this dietary level of isoflavone
may counteract the physiological activity of SREBP-1a to
increase the expression of genes involved in lipogenesis and
fatty acid desaturation.
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Fig .1  Effect of dietary soy isoflavone on mRNA levels of SREBP-1a and -1c.  
The values were expressed as percentages, assigning the value in animals fed a diet free of isoflavone as 100. Values represent
means ± SE of 7 or 8 rats. Values with different superscript differ significantly at p<0.05.
We showed that isoflavone at low dietary levels increased
mRNA expression of SREBP-1-dependent genes, whereas a
diet high in isoflavone decreased these parameters. Genistein
and daidzein have similar molecular weights and structural
characteristics to that of 17β-estradiol and hence exerts estro-
genic or anti-estrogenic action24). In addition, genistein and
daidzein affect adipogenesis through PPARγ-dependent
mechanism4). Dang and his colleagues25) demonstrated that
genistein at a low concentration (1μM) stimulates osteogene-
sis and suppresses adipogenesis through the interaction with
estrogen receptors. However, at high concentrations (>1μM),
genistein acted as a ligand for PPARγ and hence up-regulat-
ed adipogenesis and down-regulated osteogenesis.
Furthermore, it has been demonstrated that the growth of
estrogen-responsive breast cancer cells was stimulated by
genistein at the concentration of 10
-2 μM, was but was sup-
pressed at the concentration of 10μM26). Apparently, physio-
logical responses to varying doses of genistein were biphasic
in several cases. Therefore, the observed biphasic alterations
by different dietary levels of isoflavone in mRNA expressions
of SREBP-1-dependent genes are not surprising.
In conclusion, our study showed that isoflavone at dietary
levels greater than 0.1% increased the mRNA level of
SREBP-1a in liver; while a diet containing 0.4% of
isoflavone decreased the value of SREBP-1c. Diets contain-
ing 0.1-0.2% of isoflavone compared to an isoflavone-free
diet significantly increased mRNA expressions of SREBP-1-
dependent genes. However, the 0.4% isoflavone diet
decreased mRNA expression of these genes to the level
observed in rats fed an isoflavone-free diet. Therefore, pres-
ent study demonstrated that varying amounts of dietary
isoflavone modulated the mRNA expressions of SREBP-1a
and -1c differently. The observed changes in mRNA levels
may account for the biphasic modulations by different dietary
levels of isoflavone in the expression of SREBP-1-dependent
genes.
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大豆イソフラボンが脂肪酸代謝に関わる転写因子、
ステロール調節エレメント結合タンパク質（SREBP）-
1と、SREBP-1に応答する脂肪酸代謝系遺伝子の発現に
及ぼす影響をラットで調べた。ラットに0、0.05、0.1、
0.2、または0.4％の大豆イソフラボンを含む20％パーム
油食を与え、14日間飼育した。肝臓のSREBP-1aの
mRNA発現量は、イソフラボン無添加食群、または
0.05％イソフラボン食群と比べ、0.1％以上のイソフラ
ボンを含む食餌群で増加した。SREBP-1cの発現は、イ
ソフラボン無添加食群と比べ0.05-0.2％イソフラボン食
群では差はなかったが、0.4％イソフラボン食群では約
50％減少した。SREBP-1に応答する脂肪酸合成酵素や
脂肪酸不飽和化酵素の遺伝子発現は、食餌へのイソフ
ラボン添加で増加し、0.1または0.2％イソフラボン食群
で最大値を示したが、0.4％イソフラボン食群ではイソ
フラボン無添加食と同程度の発現量にまで減少した。
以上のように、SREBP-1aとSREBP-1cのmRNA発現量は
食餌中のイソフラボン添加量に従って互いに異なった
変化を示した。食餌へのイソフラボン添加量に呼応し
たSREBP-1依存性遺伝子発現量の二相性の変化は、こ
のようなSREBP-1アイソフォームのmRNA発現変化に起
因すると考えられた。
大豆イソフラボンが高飽和脂肪食摂取ラット肝臓の
SREBP-1応答遺伝子の発現に与える影響
高橋　陽子・井手　隆
食品総合研究所
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